6 DETECTION OF MICROCHIMERISM AFTER PRETRANSPLANT BLOOD TRANSFUSIONS

[1]  D. Gallardo,et al.  PCR-Based Methodology for Molecular Microchimerism Detection and Quantification , 2008, Experimental biology and medicine.

[2]  H. Nakauchi,et al.  Recipient-derived cells after cord blood transplantation: dynamics elucidated by multicolor FACS, reflecting graft failure and relapse. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  D. Gallardo,et al.  Early Hematopoietic Microchimerism Predicts Clinical Outcome After Kidney Transplantation , 2007, Transplantation.

[4]  M. Busch,et al.  Transfusion‐associated microchimerism , 2007, Vox Sanguinis.

[5]  R. Zinkernagel,et al.  Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. , 2005, The Journal of clinical investigation.

[6]  D. Roelen,et al.  The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. , 2005, Transfusion medicine reviews.

[7]  M. Busch,et al.  High‐level long‐term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury , 2005, Transfusion.

[8]  K. Khosrotehrani,et al.  Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse , 2005, Journal of Cell Science.

[9]  W R Mayr,et al.  Nomenclature for factors of the HLA system, 2004 , 2005, Tissue antigens.

[10]  F. Claas.  Chimerism as a tool to induce clinical transplantation tolerance. , 2004, Current opinion in immunology.

[11]  M. Busch,et al.  Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. , 2004, The Journal of trauma.

[12]  H. Waldmann,et al.  Dominant transplantation tolerance. Opinion. , 2003, Current opinion in immunology.

[13]  D. Greiner,et al.  Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning. , 2003, The Journal of clinical investigation.

[14]  F. Delmonico,et al.  Induction Of Kidney Allograft Tolerance After Transient Lymphohematopoietic Chimerism In Patients With Multiple Myeloma And End-Stage Renal Disease1 , 2002, Transplantation.

[15]  U. Dahmen,et al.  Flow cytometric "rare event analysis": a standardized approach to the analysis of donor cell chimerism. , 2002, Journal of immunological methods.

[16]  C. Ricordi,et al.  SIX-YEAR CLINICAL EFFECT OF DONOR BONE MARROW INFUSIONS IN RENAL TRANSPLANT PATIENTS1 , 2001, Transplantation.

[17]  Sujuan Gao,et al.  Microchimerism and rejection: a meta‐analysis , 2000 .

[18]  B. Schiedlmeier,et al.  Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. , 2000, Blood.

[19]  S. Fuggle,et al.  Nested polymerase chain reaction with sequence-specific primers typing for HLA-A, -B, and -C alleles: detection of microchimerism in DR-matched individuals. , 1999, Blood.

[20]  R. Jindal,et al.  Prospective study of microchimerism in transplant recipients , 1999, Clinical transplantation.

[21]  Sunny Dizk.  Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion , 1999 .

[22]  S. Fuggle,et al.  Detection of microchimerism after allogeneic blood transfusion using nested polymerase chain reaction amplification with sequence-specific primers (PCR-SSP): a cautionary tale. , 1998, Blood.

[23]  T. Howard,et al.  Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. , 1997, Transplantation.

[24]  D. Sachs,et al.  Chimerism and transplantation tolerance: cause and effect. , 1996, Immunology today.

[25]  K. Wood,et al.  Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence. , 1995, Transplantation.

[26]  Tzong-Hae Lee,et al.  Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. , 1995, Blood.

[27]  M. Andrien,et al.  Detection of blood chimerism after lung and heart-lung transplantation. The superiority of nested as compared with standard polymerase chain reaction amplification. , 1994, Transplantation.

[28]  C. Bodemer,et al.  Microchimerism frequency two to thirty years after cadaveric kidney transplantation. , 1994, Human immunology.

[29]  C. Bodemer,et al.  Peripheral microchimerism in long-term cadaveric-kidney allograft recipients , 1994, The Lancet.

[30]  M. Karck,et al.  Patterns of donor-type microchimerism after heart transplantation , 1994, The Lancet.

[31]  B. Griffith,et al.  Mixed allogeneic chimerism in lung allograft recipients. , 1994, Human pathology.

[32]  T. Starzl,et al.  CHIMERISM AND DONOR‐SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION , 1993, Transplantation.

[33]  T. Starzl,et al.  Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance , 1993, Hepatology.

[34]  T. Starzl,et al.  Systemic chimerism in human female recipients of male livers , 1992, The Lancet.

[35]  D. Reardon,et al.  Detection of circulating donor white blood cells in patients receiving multiple transfusions. , 1992, Blood.

[36]  T. Starzl,et al.  Cell migration, chimerism, and graft acceptance , 1992, The Lancet.

[37]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[38]  J. Gmür.  [Allogeneic bone marrow transplantation]. , 1988, Therapeutische Umschau. Revue therapeutique.

[39]  Rainer Blasczyk,et al.  Nomenclature for factors of the HLA system , 1998 .